|
LCMT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.726000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.302200E-01 |
| Normal-vs-Stage2 |
6.302400E-02 |
| Normal-vs-Stage3 |
9.543800E-03 |
| Normal-vs-Stage4 |
7.916200E-03 |
| Stage1-vs-Stage2 |
3.598000E-01 |
| Stage1-vs-Stage3 |
6.845800E-02 |
| Stage1-vs-Stage4 |
2.737000E-01 |
| Stage2-vs-Stage3 |
5.115400E-01 |
| Stage2-vs-Stage4 |
6.250800E-01 |
| Stage3-vs-Stage4 |
9.137200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.303600E-02 |
| Normal-vs-AfricanAmerican |
4.680000E-02 |
| Normal-vs-Asian |
2.619100E-03 |
| Caucasian-vs-AfricanAmerican |
7.112400E-01 |
| Caucasian-vs-Asian |
1.997350E-01 |
| AfricanAmerican-vs-Asian |
1.092000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.246000E-02 |
| Normal-vs-Female |
2.432200E-01 |
| Male-vs-Female |
6.519400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.117960E-01 |
| Normal-vs-Extreme_Weight |
2.051600E-01 |
| Normal-vs-Obese |
6.663700E-02 |
| Normal-vs-Extreme_Obese |
9.557000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.196600E-01 |
| Normal_Weight-vs-Obese |
9.224600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.751200E-01 |
| Extreme_Weight-vs-Obese |
6.180600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.630000E-01 |
| Obese-vs-Extreme_Obese |
3.588800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.787830E-01 |
| Normal-vs-Age(41-60Yrs) |
3.956400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.097550E-02 |
| Normal-vs-Age(81-100Yrs) |
3.784200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.122200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.936000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.720000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.186790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.462000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.027000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.767600E-01 |
| Normal-VS-Type2 PRCC |
3.237300E-04 |
| Normal-VS-KIRP CIMP |
3.20690030086723E-10 |
| Normal-VS-Unclassified PRCC |
7.252300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.405000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.62320157315321E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
1.427210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.560800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.444000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.784100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.155800E-04 |
| Normal-vs-N1 |
1.396620E-03 |
| Normal-vs-N2 |
7.163700E-04 |
| N0-vs-N1 |
6.299600E-01 |
| N0-vs-N2 |
2.865800E-01 |
| N1-vs-N2 |
3.708800E-01 |
|
|
